| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $3.5M | +107.8% | +38.6% |
| Cost of Revenue | $5.0M | +90.3% | +436.7% |
| Gross Profit | -$1.4M | -57.7% | -188.5% |
| R&D Expense | $290K | +13.0% | -14.9% |
| SG&A Expense | $662K | -15.1% | +15.1% |
| Operating Income | -$8.8M | -299.1% | -1681.9% |
| Pre-tax Income | -$8.8M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $41K | -96.2% | — |
| Accounts Receivable | $2.5M | -10.8% | +26.6% |
| Inventory | $3.5M | -1.2% | -8.6% |
| Current Assets | $6.6M | -19.2% | +8.9% |
| Total Assets | $15.0M | -9.4% | +2.7% |
| Current Liabilities | $9.0M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$3.8M | — | — |
| Investing Cash Flow | -$1.0M | — | — |
| Financing Cash Flow | $3.8M | — | — |
| -289.1% |
| -1872.0% |
| Income Tax | $0 | — | +100.0% |
| Net Income | -$8.8M | -289.1% | -1872.0% |
| EPS (Basic) | -$0.07 | -250.0% | -450.0% |
| EPS (Diluted) | -$0.07 | -250.0% | -450.0% |
| +12.7% |
| -21.7% |
| Total Liabilities | $13.1M | +8.1% | -0.5% |
| Stockholders' Equity | $1.8M | -57.9% | +32.8% |